MCG
USNA icon

Meru Capital Group’s Usana Health Sciences USNA Stock Holding History

Meru Capital Group’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-6,000
Closed -$410K – 44
2015
Q2 		$410K Sell
6,000
-21,680
-78% -$1.38M 0.09% 43
2015
Q1 		$1.54M Buy
+27,680
New +$1.42M 0.35% 40

Other funds holding USNA

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Meru Capital Group's USNA Position: Q3 2015 in Review

Meru Capital Group sold out of Usana Health Sciences (USNA) in Q3 2015, closing a stake of 6,000 shares — an estimated $410K sold.

Meru Capital Group first reported a position in USNA in Q1 2015 and held it in 2 quarters. The position peaked at $1.54M in Q1 2015. 166 funds tracked by Wall St. Rank hold USNA as of Q3 2015.

  • Meru Capital Group reported no remaining Usana Health Sciences position as of Q3 2015 after selling out during the quarter.
  • Meru Capital Group sold 6,000 Usana Health Sciences shares in Q3 2015, an estimated $410K.
  • Meru Capital Group first reported a position in Usana Health Sciences in Q1 2015 and held it in 2 quarters.
  • Meru Capital Group's Usana Health Sciences position peaked at $1.54M in Q1 2015.
  • 166 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2015.

Based on Meru Capital Group's 13F filing for Q3 2015, filed 16 Nov 2015.